Financing channel feed – Endpoints News

Financing channel feed

GlaxoSmithKline R&D vet Min Li nabs $100M to launch a Bob Nelsen-backed startup focused on China’s burgeoning neuro market

5 years ago

Is there room for a new way to drug RNA? ARCH, Foresite join Atlas, The Column Group for $81M bet

5 years ago

#ASH20: Bain execs step in to position a somewhat battered and bruised Syros with a new clinical candidate and enough money to charge ahead

5 years ago

Four biotechs hit Wall Street with upsized IPOs, each raising more than $20M over their goals

5 years ago

A high-profile ‘angel’ joins the Silicon Valley crew backing an anti-aging upstart with an eye on PhII

5 years ago

Laura Shawver is about to join a lineup of biotech CEOs enjoying overnight fortunes, courtesy of the biotech IPO boom

5 years ago

A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline

5 years ago

Corey Goodman introduces Tallac Therapeutics with a $62M Series A, hoping to fight solid tumors through innate and adaptive immunity

5 years ago

Roche shelved these psychiatry drugs. So its former head of neuro cooked up some new plans — and raised $59M for his startup

5 years ago

Kinaset launches with $40M and a JAK inhibitor from Vectura's old pipeline

5 years ago

Scoop: Google’s GV spearheads the Spotlight syndicate — backing an upstart biotech aimed at ‘democratizing’ gene editing

5 years ago

China opens the door for biotech investors in Hong Kong to buy Shanghai stocks, and vice versa

5 years ago

Medable gets $91M for virtual clinical trials, bringing total raise to $136M

5 years ago

After 5 quiet years, a former Scripps spinout raises $200M and announces plans to try again at an IPO

5 years ago

Overnight fortunes are being made in biotech these days — and it's both encouraging and more than a little bit scary

5 years ago

Tech billionaire Peter Thiel backs a leading psychedelic drug developer

5 years ago

From a pair of Air Jordans to a $200M-plus IPO, Carl Hansen is crafting an overnight R&D fortune fueled by Covid-19

5 years ago

Catamaran Bio sails into the CAR-NK waters with a $42M launch round

5 years ago

Syncona launches new gene therapy player Purespring, spun out of the University of Bristol, with a roughly $60M Series A

5 years ago

Sean Bohen hauls in a multimillion-dollar windfall as his newly adopted biotech bags a $209M-plus IPO

5 years ago

Blood cancer player Imago Biosciences caps off an $80M Series C with an IPO promise for 2021

5 years ago

Scoop: SR One crew completes a complicated spinout from GlaxoSmithKline. And now they have a $500M fund to invest on their own

5 years ago

An Oxford spinout raises $44M as it looks to resurrect an old Roche antibody in pursuit of a rare disease

5 years ago

4DMT shoots for a $75M IPO, its second attempt to go public with its gene therapy vector programs

5 years ago

First page Previous page 86 87 888990 91 92 Next page Last page